Effects of IV glucose and oral medium-chain triglyceride in patients with VLCAD deficiency.
Ørngreen
M C
MC
Neuromuscular Research Unit, the Copenhagen Muscle Research Center and the Department of Neurology, National University Hospital, Rigshospitalet, Copenhagen, Denmark.
Nørgaard
M G
MG
van Engelen
B G M
BG
Vistisen
B
B
Vissing
J
J
D044942:Acyl-CoA Dehydrogenase, Long-Chain / Q000172:deficiency*; D000284:Administration, Oral; D000328:Adult; D005080:Exercise Test / Q000187:drug effects; D005947:Glucose / Q000008:administration & dosage*; D044882:Glucose Metabolism Disorders / Q000188:drug therapy / Q000201:enzymology; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D014280:Triglycerides / Q000008:administration & dosage*
D014280:Triglycerides; D044942:Acyl-CoA Dehydrogenase, Long-Chain; D005947:Glucose